Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2006
This study will test the effectiveness and safety of two doses of solabegron against placebo in reducing the symptoms of overactive bladder.
Epistemonikos ID: 991ee16ced587434223954db0acd17a1385af2de
First added on: May 04, 2024